Flora Growth (NASDAQ:FLGC – Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.42) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.31), Zacks reports. Flora Growth had a negative net margin of 30.99% and a negative return on equity of 268.17%.
Flora Growth Stock Performance
NASDAQ:FLGC opened at $0.66 on Tuesday. The firm has a 50 day moving average of $0.80 and a 200 day moving average of $1.18. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.02 and a quick ratio of 0.64. Flora Growth has a 52 week low of $0.59 and a 52 week high of $2.93.
Analyst Ratings Changes
Separately, Aegis initiated coverage on Flora Growth in a report on Monday, November 25th. They issued a “buy” rating and a $4.00 price target on the stock.
About Flora Growth
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.
Further Reading
- Five stocks we like better than Flora Growth
- 10 Best Airline Stocks to Buy
- Can SoundHound AI Double? What the Fundamentals and Deals Reveal
- How Can Investors Benefit From After-Hours Trading
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- What Makes a Stock a Good Dividend Stock?
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
Receive News & Ratings for Flora Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flora Growth and related companies with MarketBeat.com's FREE daily email newsletter.
